Clinical Trial Update: A Study to Evaluate Efficacy and Safety of AVTX-803 in Patients with Leukocyte Adhesion Deficiency Type II [Phase 3]

View source ↗

Summary

This clinical trial update concerns AVTX-803 in a Phase 3 study for Leukocyte Adhesion Deficiency Type II to evaluate efficacy and safety. The study status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukocyte Adhesion Deficiency Type Ii

Drugs mentioned

• AVTX-803

Snippet

Sponsor: AUG Therapeutics | Conditions: Leukocyte Adhesion Deficiency | Phase 3 | Status: UNKNOWN